Nature Reviews Cancer contents May 2018 Volume 18 Number 5 265-373

If you are unable to see the message below, click here to view.

Advertisement EXPLORE HUMANIZED MICE IN PRECLINICAL IMMUNO-ONCOLOGY  Discover the strengths and limitations of human immune system-engrafted mice and understand how choosing the right model is critical to effective preclinical immuno-oncology efforts. Learn How To:  Leverage foundational humanized immune system models  Evaluate humanized models used in combinatorial treatment strategies Watch this Webinar TABLE OF CONTENTS May 2018 Volume 18, Issue 5 Research Highlights Reviews Perspectives   Advertisement   Do you have a career question? The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud.  Listen today!   Advertisement Gain Insights into Cancer Research Metabolic reprogramming is a critical area of research and potential therapeutic strategy for cutaneous squamous cell carcinoma. Learn how the new, quantitative Agilent Seahorse XF Glycolytic Rate Assay can be used for cancer drug screening and to reveal mechanisms of action. Watch the webinar to learn more.   Advertisement Nature Milestone: Anticoagulants from Nature Reviews Cardiology  This Milestone plots the history of anticoagulant drugs, used to prevent and treat thrombotic disorders in millions of patients worldwide. Fourteen Milestone articles are presented on an interactive timeline with associated multimedia.  Access free online >> Produced with support from:  Portola Pharmaceuticals, Inc.    Research Highlights   Breast cancer: Obesity � tipping the scales of resistance    p265 Conor A. Bradley doi:10.1038/nrc.2018.31 Using clinical tissue specimens and mouse models of breast cancer, Incio et al. show that obesity promotes the upregulation of interleukin-6 and fibroblast growth factor 2 in the tumour microenvironment, which confer resistance to anti-vascular endothelial growth factor therapy. Leukaemia: Powers of prediction    pp372 - 373 Anna Dart doi:10.1038/nrc.2018.28 Good et al. use deep phenotypic single-cell analyses and machine learning to identify developmentally dependent cell signalling states in B cell precursor acute lymphoblastic leukaemia that are predictive of relapse. Breast cancer: External communication    pp372 - 373 Ulrike Harjes doi:10.1038/nrc.2018.30 In a new study, researchers show that basal-like breast cancer can be converted into the luminal subtype by inhibiting platelet-derived growth factor (PDGF)-CC signalling in the tumour microenvironment, thereby potentially broadening treatment options for oestrogen receptor-negative breast cancer patients. Pancreatic cancer: The COMPASS shows the way    p373 Sarah Seton-Rogers doi:10.1038/nrc.2018.29 Deregulation of the COMPASS-like complex, via loss of KDM6A in females and loss of both KDM6A and its Y chromosome homologue UTY in males, is important for activation of oncogene-associated super-enhancers and the development of pancreatic adenocarcinoma of the squamous subtype. Nature Reviews Cancer JOBS of the week Post-Doctoral Associate St. Jude Children's Research Hospital (SJCRH), Department of Surgery Postdoctoral Fellow Indiana Uniersity School of Medicine Group leader Oncology Sanofi Post-doctoral Researcher in Cancer and Epigenetics International Clinical Research Center More Science jobs from Nature Reviews Cancer EVENT New Technologies in Cancer Mechanobiology 20.06.18 Buckinghamshire, UK More science events from Reviews   The molecular landscape of head and neck cancer    pp269 - 282 C. René Leemans, Peter J. F. Snijders & Ruud H. Brakenhoff doi:10.1038/nrc.2018.11 Head and neck cancer is an unexpectedly heterogeneous disease. In this Review, Leemans, Snijders and Brakenhoff provide an update on the molecular biology of head and neck cancer, outline the role of human papillomavirus and discuss the functional role of genes involved in malignant progression to identify subgroups to personalize treatment. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation    pp283 - 295 Yusuke Shono & Marcel R. M. van den Brink doi:10.1038/nrc.2018.10 Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment for many haematopoietic malignancies but often results in life-threatening complications, such as graft-versus-host disease, relapse and infections. This Review discusses the potential role of intestinal microbiota in complications after allo-HSCT. Cell motility in cancer invasion and metastasis: insights from simple model organisms    pp296 - 312 Christina H. Stuelten, Carole A. Parent & Denise J. Montell doi:10.1038/nrc.2018.15 In this Review, Stuelten et al. outline insights with relevance to human cancer invasion and metastasis that have come from the study of cell motility in non-mammalian model organisms. Advertisement Searching for a new career?  At Nature Research we frequently recruit talented individuals to join our editorial and publishing teams. If you have a PhD and a passion for science this may be the perfect career for you. Visit our research editorial and publishing careers website to discover more about what we do.   Perspectives   Opinions Using immunotherapy to boost the abscopal effect    pp313 - 322 Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, Jürgen Hesser, Sandra Demaria et al. doi:10.1038/nrc.2018.6 The abscopal effect, which is the regression of metastatic cancer at distant sites during radiotherapy, is somewhat rare but can be promoted by immunotherapy. This Opinion article describes emerging concepts and limitations of using a combination of radiotherapy and immunotherapy to boost the abscopal effect. Non-angiogenic tumours and their influence on cancer biology    pp323 - 336 Tom Donnem, Andrew R. Reynolds, Elizabeth A. Kuczynski, Kevin Gatter, Peter B. Vermeulen et al. doi:10.1038/nrc.2018.14 In this Opinion article, Donnem et al. outline the evidence for non-angiogenic tumours, which use pre-existing blood vessels to support tumour growth, and discuss the studies that are beginning to define their unique biology. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount (You will need to log in to be recognised as a nature.com registrant) For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our customer feedback department Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.